Xenon Pharmaceuticals 10.5M share Spot Secondary priced at $57.00

Finviz2026/03/11 10:03

By:Finviz

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

The deal size was increased to $650M in common stock from $500M in common stock. JPMorgan, Jefferies, TD Cowen, Stifel, and William Blair acted as joint book running managers for the offering.

Claim 70% Off TipRanks Premium

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential

Published first on – the ultimate source for real-time, market-moving breaking financial news.

See the top stocks recommended by analysts >>

Read More on XENE:

Xenon Raises $650 Million in Upsized U.S. Equity Offering
Xenon Pharmaceuticals: Buy Rating Backed by Superior X-TOLE2 Phase 3 Results and Commercial Upside for Azetukalner in Focal Epilepsy
Xenon Pharmaceuticals price target raised to $64 from $47 at Wedbush
Xenon Pharmaceuticals price target raised to $90 from $60 at Guggenheim
Xenon Pharmaceuticals price target raised to $68 from $49 at Wells Fargo

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Xenon Pharmaceuticals 10.5M share Spot Secondary priced at $57.00

Claim 70% Off TipRanks Premium

You may also like

Crypto prices